GUK1 is a novel metabolic liability in oncogene-driven lung cancer

被引：0
|
作者：
Schneider, Jaime Laurel
Kurmi, Kiran
Dhiman, Ishita
Colapietro, Roberta
Joshi, Shakchhi
Johnson, Christian
Yoda, Satoshi
Paulo, Joao
Ruiz, Daniela
Stopka, Sylwia
Baquer, Gerard
Lin, Jessica
Haigis, Kevin
Agar, Nathalie
Gygi, Steven
Hata, Aaron
Haigis, Marcia
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-1156
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1156
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Oncogene-Driven Metabolic Alterations in Cancer
    Min, Hye-Young
    Lee, Ho-Young
    [J]. BIOMOLECULES & THERAPEUTICS, 2018, 26 (01) : 45 - 56
  • [2] EGFR: The Paradigm of an Oncogene-Driven Lung Cancer
    Riely, Gregory J.
    Yu, Helena A.
    [J]. CLINICAL CANCER RESEARCH, 2015, 21 (10) : 2221 - 2226
  • [3] Screening for TWIST1 inhibitors as a novel therapy for oncogene-driven lung cancer.
    Chatley, Sarah N. H.
    Cades, Jessica A.
    Neumann, Neil M.
    Mazzacurati, Lucia
    Yochum, Zachary A.
    Nugent, Katriana
    Cho, Yoon-Jae
    Ewald, Andrew J.
    Rudin, Charles M.
    Tran, Phuoc T.
    Burns, Timothy F.
    [J]. CLINICAL CANCER RESEARCH, 2014, 20
  • [4] ATLANTIC: a sea change in immunotherapy for oncogene-driven lung cancer?
    Lin, Jessica J.
    Gainor, Justin F.
    [J]. LANCET ONCOLOGY, 2018, 19 (04): : 438 - 439
  • [5] Inflammation and cancer: The oncogene-driven connection
    Borrello, Maria Grazia
    Degl'Innocenti, Debora
    Pierotti, Marco A.
    [J]. CANCER LETTERS, 2008, 267 (02) : 262 - 270
  • [6] Oncogene-Driven Hemostatic Changes in Cancer
    Rak, Janusz
    Yu, Joanne
    Milsom, Chloe
    [J]. CANCER INVESTIGATION, 2009, 27 : 28 - 35
  • [7] PROS: should immunotherapy be incorporated in the treatment of oncogene-driven lung cancer?
    Addeo, Alfredo
    Banna, Giuseppe Luigi
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2018, 7 : S287 - S289
  • [8] Cons: should immunotherapy be incorporated in the treatment of oncogene-driven lung cancer?
    Metro, Giulio
    Di Maio, Massimo
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2018, 7 : S294 - S296
  • [9] Cons: should immunotherapy be incorporated in the treatment of oncogene-driven lung cancer?
    Metro, Giulio
    Di Maio, Massimo
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2018, 7 : S290 - S293
  • [10] Treatment of oncogene-driven non-small cell lung cancer
    Kastelijn, Elisabeth A.
    de Langen, Adrianus J.
    Peters, Bas J. M.
    [J]. CURRENT OPINION IN PULMONARY MEDICINE, 2019, 25 (03) : 300 - 307
12345